COMP/Thrombospondin-5 Antibody

Product Discontinued

COMP/Thrombospondin-5 Antibody Summary

• Immunogen: A 16 residue synthetic peptide derived from specific domain of Complexe Oligomatrix Protein
• Specificity: Reacts specifically with COMP from cartilage matrix
• Clonality: Polyclonal
• Host: Rabbit
• Gene: COMP
• Purity: Immunogen affinity purified

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry 1:20 - 1:100
  • Immunohistochemistry-Paraffin 1:20 - 1:100
  • Western Blot 1:20-1:200

Packaging, Storage & Formulations

• Storage: Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
• Buffer: 0.1M Tris , 0.1M Glycine, 50% Glycerol, pH 7.8
• Preservative: 0.02% Sodium Azide
• Purity: Immunogen affinity purified

Alternate Names for COMP/Thrombospondin-5 Antibody

• cartilage oligomeric matrix protein (pseudoachondroplasia, epiphyseal dysplasia1, multiple)
• cartilage oligomeric matrix protein
• cartilage oligomeric matrix protein(pseudoachondroplasia, epiphyseal dysplasia1, multiple)
• COMP
• EDM1
• EPD1
• MED
• MEDMGC131819
• MGC149768
• PSACH
• pseudoachondroplasia (epiphyseal dysplasia 1, multiple)
• THBS5
• Thrombospondin5
• Thrombospondin-5
• TSP5

Background

COMP is a noncollagenous extracellular matrix (ECM) protein. It consists of five identical glycoprotein subunits, each with EGF like and calcium binding (thrombospondin like) domains. Oligomerization results from formation of a five stranded coiled coil and disulfides. Binding to other ECM proteins such as collagen appears to depend on divalent cations. Mutations can cause the osteochondrodysplasias pseudochondroplasia (PSACH) and multiple epiphyseal dysplasia (MED)

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for COMP/Thrombospondin-5 Antibody (NB100-2478)(2)

Publications using NB100-2478

• Doldi V, Lecchi M, Ljevar S et al. Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer International journal of molecular sciences 2022-07-20 [PMID: 35887333] (WB, Human)
• Giussani M, Landoni E, Merlino G et al. Extracellular matrix proteins as diagnostic markers of breast carcinoma. J. Cell. Physiol. 2018-03-09 [PMID: 29521413] (Human)

FAQs for COMP/Thrombospondin-5 Antibody (NB100-2478). (Showing 1 - 1 of 1 FAQs).

1. I have synovial fluid sample and I want to work on Western bloting can you support me ,how can I prepare this sample for WB technique for assay comp(cartilage oligomatrix protein )?
   • We currently sell four antibodies to cartilage oligomeric matrix protein (COMP), all of which are validated for Western blotting. Although we have generated Western blot data using samples from human, bovine and rabbit cartilage, we do not have any testing data derived from synovial fluid samples. You may however find the following publication useful, in which the authors sampled synovial fluid from patients with rheumatoid arthritis and prepared this fluid for Western blot detection of the proteins SP-A and SP-D: PMC 2080374

Bioinformatics

• Gene Symbol: COMP
• Entrez:
  • 1311(Human)
• Uniprot:
  • P49747()